Free
01
Online Course
All the necessary information to smoothly transition to Augma bone cement.
Read MoreAll the necessary information to smoothly transition to Augma bone cement.
Read MoreA range of clinical cases by ABCA Bone Cement Experts. Sinus Lift, Lateral Augmentation, Socket Grafting, and more.
Read MoreRead More
Review, critical assessment and evaluation of research studies on Bone Cement.
Biphasic Calcium Sulfate as 2nd generation technological breakthrough in the long history of CS bone regeneration
Read MoreWhy flap with tension? Why no membranes? How come maximal closure is acceptable?
Read MoreThe course is aimed to provide all the necessary information to smoothly transition to Augma bone cement from traditional grafting and shorten the learning curve to minimal.
*US CLINICIANS EARN 0.5 CE*
The initial stability for any implant is due to placement in the residual bone. The purpose of bone graft cement is to regenerate bone around the implant. It has no continuous cementing properties. Bond Apatite has bioactive properties to regenerate bone.
Biphasic calcium sulfate is a patented formulation of calcium sulfate. This is the only formulation of calcium sulfate that has the ability to behave as a cement in the oral cavity. Additionally, the BCS is moldable and can set and harden instantly in the presence of blood and saliva. The old calcium sulfate could not set and harden when it got it to contact with blood or saliva; therefore, it could not be easily used as a suitable cement in the maxillofacial field.
The working time with Bond Apatite® starts when the powder is mixed with saline by advancing the plunger in the smart syringe and introducing the saline in to the premeasured BCS/HA powder chamber. At this time, the material is moldable and pliable. The best pliability is seen immediately after cement activation. Thus, it is vital to have the host site completely prepared before the activation of Bond Apatite®. After the site has been prepared, activate the cement within its smart syringe and eject it into the site. As soon as Bond Apatite® is placed in the site, it should be compressed with a dry sterile gauze pad for 3 seconds, and then the material hardens in situ immediately. The compression should be done by applying finger pressure on the gauze for 3 seconds, followed by an additional few seconds' compactions with a periosteal elevator on the gauze. Once completed, remove the gauze and continue with soft tissue closure according to the protocols.
In the oral cavity, pressing with gauze for 3 seconds generates an instant primary setting. In vitro hardening takes approximately 3-5 minutes.
As can be seen in the protocols, it is recommended to activate the cement within its smart syringe after complete site preparation, injec the cement directly into the site, and immediately place a dry sterile gauze pad above and press with a finger on top for 3 seconds. This should be followed by an additional few seconds' pressure on the gauze with a periosteal elevator.
The material does not remain hard. The resorbtion process begins immediately after placement, while new bone formation simultaneously takes place.
Due to the nature of the graft, the biphasic calcium sulfate matrix within the graft is simultaneously replaced by the patient’s bone; therefore, the radiographic appearance is completely different compared to other grafts, which always appear radiopaque due to their constant presence in the grafted site.
In contrast, the radiographic appearance with Bond Apatite® is as follows:
During day one after graft placement, it appears radiopaque.
Gradually, a radiolucent appearance takes its place (reflecting the graft's transformation into the newly-formed osteoid before its calcification).
Two to four weeks after graft placement, the majority of the grafted site appears radiolucent while few radiopaque spots remain, reflecting the presence of the HA particles. Within 12 weeks, radiopacity takes place with the appearance of the native trabecular form. This is the time when the new osteoid has already calcified.
There is no recommended specific protocol at this point for vertical augmentation.